Sensus Healthcare Q2 EPS $(0.02) Beats $(0.08) Estimate, Sales $4.53M Miss $4.55M Estimate
Portfolio Pulse from totan@benzinga.com
Sensus Healthcare reported Q2 losses of $(0.02) per share, beating the analyst consensus estimate of $(0.08) by 75%. However, the company's quarterly sales of $4.53 million missed the analyst consensus estimate of $4.55 million by 0.51%. This represents a 109.52% decrease in earnings and a 62.52% decrease in sales compared to the same period last year.
August 04, 2023 | 2:29 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Sensus Healthcare's Q2 earnings beat estimates but sales missed, with significant YoY decreases in both earnings and sales.
Sensus Healthcare's Q2 results showed a significant decrease in both earnings and sales compared to the same period last year. While the company beat earnings estimates, it missed on sales, which could negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100